title: Smoking cessation in patients with chronic kidney disease.
authors.affiliation: ACPR, Winnipeg Regional Health Authority, Manitoba Renal Program, Winnipeg, MB. craymond@exchange.hsc.mb.ca
authors.forename: Colette B
authors.initials: CB
authors.lastname: Raymond
authors.forename: Heather K
authors.initials: HK
authors.lastname: Naylor
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects / Q000627:therapeutic use; D001552:Benzazepines / Q000009:adverse effects / Q000627:therapeutic use; D016642:Bupropion / Q000009:adverse effects / Q000627:therapeutic use; D002170:Canada; D006801:Humans; D009538:Nicotine / Q000008:administration & dosage / Q000009:adverse effects; D018722:Nicotinic Agonists / Q000009:adverse effects / Q000627:therapeutic use; D011810:Quinoxalines / Q000009:adverse effects / Q000627:therapeutic use; D051436:Renal Insufficiency, Chronic; D012907:Smoking / Q000188:drug therapy* / Q000523:psychology; D016540:Smoking Cessation / Q000379:methods*; D000068580:Varenicline
chemical_list: D018687:Antidepressive Agents, Second-Generation; D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D016642:Bupropion; D009538:Nicotine; D000068580:Varenicline